|
Imaging Biometrics Ltd on Wednesday said it has expanded its global distribution agreement with GE Healthcare Technologies Inc to widen access to two of its advanced neuroimaging products, FTB Express and QSMetric. The healthcare imaging software firm said the amendment adds the offerings to an existing distribution deal that already covers its IB Neuro and Delta T1 mapping tools, which are used to support diagnosis and monitoring in brain tumour patients. Shares in Imaging Biometrics were 16% higher at 1.04 pence in London at midday on Wednesday. GE Healthcare shares were 0.6% lower at $82.54 during premarket trading in New York. FTB Express provides accelerated generation of fractional tumor burden maps, offering automated visualisation that distinguishes tumour tissue from treatment-related effects. QSMetric, meanwhile, is a patented quantitative susceptibility tool designed to analyse gradient-echo MRI data to visualise tissue structures. Imaging Biometrics said the expanded agreement will ‘broaden access’ to the technologies across GE HealthCare’s customer base. Katie Anderson, global MR visualisation product manager at GE HealthCare, said: ‘We are excited to expand our collaboration with Imaging Biometrics to enable access for our customers to these clinically important capabilities.’ Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
